Cargando…
Tubeimoside I induces autophagy in HepG2 cells by activating the AMP-activated protein kinase signaling pathway
Tubeimoside I (TBMS) is a natural compound with antitumor properties. However, the detailed mechanism underlying the function of TBMS in liver cancer has not been fully elucidated. In the present study, TBMS was shown to suppress cell proliferation and induce S phase cell cycle arrest in HepG2 cells...
Autores principales: | Ruan, Chengxu, You, Lijuan, Qiu, Yingdong, Cui, Xiao, Wu, Defeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7291703/ https://www.ncbi.nlm.nih.gov/pubmed/32537027 http://dx.doi.org/10.3892/ol.2020.11604 |
Ejemplares similares
-
Fatsioside A-induced apoptotic death of HepG2 cells requires activation of AMP-activated protein kinase
por: ZHENG, YU-SHAN, et al.
Publicado: (2015) -
Research on the Interaction between Tubeimoside 1 and HepG2 Cells Using the Microscopic Imaging and Fluorescent Spectra Method
por: Lin, Xiaogang, et al.
Publicado: (2014) -
Ginsenoside Rg3 Reduces Lipid Accumulation with AMP-Activated Protein Kinase (AMPK) Activation in HepG2 Cells
por: Lee, Seohyun, et al.
Publicado: (2012) -
Caffeine attenuates lipid accumulation via activation of AMP-activated protein kinase signaling pathway in HepG2 cells
por: Quan, Hai Yan, et al.
Publicado: (2013) -
Inhibition of autophagy promotes CYP2E1-dependent toxicity in HepG2 cells via elevated oxidative stress, mitochondria dysfunction and activation of p38 and JNK MAPK()
por: Wu, Defeng, et al.
Publicado: (2013)